These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
3. On the question of apoptosis in the parkinsonian substantia nigra. Kösel S; Egensperger R; von Eitzen U; Mehraein P; Graeber MB Acta Neuropathol; 1997 Feb; 93(2):105-8. PubMed ID: 9039456 [TBL] [Abstract][Full Text] [Related]
10. Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Sulzer D Trends Neurosci; 2007 May; 30(5):244-50. PubMed ID: 17418429 [TBL] [Abstract][Full Text] [Related]
11. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Tatton NA Exp Neurol; 2000 Nov; 166(1):29-43. PubMed ID: 11031081 [TBL] [Abstract][Full Text] [Related]
12. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? Mouatt-Prigent A; Karlsson JO; Agid Y; Hirsch EC Neuroscience; 1996 Aug; 73(4):979-87. PubMed ID: 8809817 [TBL] [Abstract][Full Text] [Related]
13. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Tompkins MM; Basgall EJ; Zamrini E; Hill WD Am J Pathol; 1997 Jan; 150(1):119-31. PubMed ID: 9006329 [TBL] [Abstract][Full Text] [Related]
14. Iron and ferritin in substantia nigra in Parkinson's disease. Jellinger KA; Kienzl E; Rumpelmaier G; Paulus W; Riederer P; Stachelberger H; Youdim MB; Ben-Shachar D Adv Neurol; 1993; 60():267-72. PubMed ID: 8420142 [No Abstract] [Full Text] [Related]
15. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Damier P; Hirsch EC; Agid Y; Graybiel AM Brain; 1999 Aug; 122 ( Pt 8)():1437-48. PubMed ID: 10430830 [TBL] [Abstract][Full Text] [Related]
16. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Howells DW; Porritt MJ; Wong JY; Batchelor PE; Kalnins R; Hughes AJ; Donnan GA Exp Neurol; 2000 Nov; 166(1):127-35. PubMed ID: 11031089 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Anglade P; Vyas S; Javoy-Agid F; Herrero MT; Michel PP; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch EC; Agid Y Histol Histopathol; 1997 Jan; 12(1):25-31. PubMed ID: 9046040 [TBL] [Abstract][Full Text] [Related]
18. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Banati RB; Daniel SE; Blunt SB Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333 [TBL] [Abstract][Full Text] [Related]
19. Minor retinal degeneration in Parkinson's disease. Huang YM; Yin ZQ Med Hypotheses; 2011 Feb; 76(2):194-6. PubMed ID: 20933338 [TBL] [Abstract][Full Text] [Related]
20. Dopamine-induced, genotoxic activation of programmed cell death. A role in nigrostriatal neuronal degeneration in Parkinson's disease? Ziv I; Barzilai A; Offen D; Stein R; Achiron A; Melamed E Adv Neurol; 1996; 69():229-33. PubMed ID: 8615132 [No Abstract] [Full Text] [Related] [Next] [New Search]